Core Viewpoint - The 11th Bio-based Conference and Exhibition (Bio-based 2026) will be held from May 20-22, 2026, in Shanghai, focusing on the promotion of the "dual carbon" strategy and green low-carbon development in response to national policies [2][3]. Group 1: Event Overview - The event will feature 11 major thematic forums, 7 concurrent activities, and showcase over 1000 new products, including the DT New Leaf Award selection [2][3]. - More than 100 industry experts and leaders will share insights on global strategic trends, cutting-edge technologies, and supply chain collaboration [2][3]. - The expected attendance is over 1500 participants, highlighting the significance of the bio-based industry [2]. Group 2: Organizational Structure - The conference is organized by the Zhejiang Provincial Key Laboratory of Bio-based High Polymer Materials and Ningbo Detaichuang Information Technology Co., Ltd. (DT New Materials) [3][4]. - Supporting units include various national key laboratories and industry associations, emphasizing the collaborative nature of the event [4]. Group 3: Award and Recognition - The DT New Leaf Award 2026 has already received 67 new product entries from 52 units, aiming to recognize outstanding innovations in the bio-based sector [15][17]. - The award will be announced during the conference, further promoting excellence in bio-based products and technologies [15]. Group 4: Forum Structure - The conference will host 7 major material and application forums, focusing on vertical innovations from bio-based technology development to market applications [18][19]. - Key topics include critical chemicals and materials, sustainable transformation in CASE products, and advancements in bio-based packaging and textiles [19][20][22]. Group 5: Exhibition Highlights - The exhibition will showcase over 1000 new products, emphasizing innovations in bio-based materials, packaging, and engineering solutions [33][34]. - Special activities will include demand matching sessions and technical consultation meetings, facilitating industry collaboration [34].

Conference Overview - The fifth Synbio China conference will be held in Hangzhou on March 31 to April 1, 2026, at the Hilton Garden Inn [7][9] - The conference aims to gather 1,000 participants and is organized by Synbio Deep Wave and Jiangnan University [7][8] Venue and Accommodation - The main venue is the Hilton Garden Inn, located at 600 Jinsada Avenue, Qiantang District, Hangzhou [6][7] - Accommodation options include: - Hilton Garden Inn: 550 RMB per night including breakfast [6] - Holiday Inn: 238 RMB for a double room, excluding breakfast [6] - City Hotel: 238 RMB for a double room, excluding breakfast [6] Transportation - Transportation options to the venue include: - Taxi from Hangzhou East Station: approximately 25 minutes [4] - Metro from Hangzhou East Station: Line 1 to Jinsahu Station, about 30 minutes [4] - Taxi from Hangzhou Xiaoshan International Airport: approximately 40 minutes [4] Agenda Highlights - The conference will feature various sessions, including: - Day 1 AM: Focus on bio-manufacturing industry ecology and functional food science [10] - Day 1 PM: Specialized sessions on food and skincare [10] - Day 2 AM: Focus on functional ingredients and bio-manufacturing innovation [10] - Day 2 PM: Discussions on future food and all-age nutrition [10] Keynote Speakers - Notable speakers include: - An academic from the German Academy of Engineering discussing low-carbon bio-manufacturing technologies [14] - Experts from Jiangnan University and other institutions presenting on various bio-manufacturing topics [15][19] Industry Collaboration - The conference will facilitate networking and collaboration among industry professionals, researchers, and investors [34] - Opportunities for exhibitors and sponsors to showcase their products and services related to synthetic biology and bio-manufacturing [34]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models [1]. Group 1: Current Status and Trends - The "2025 China Synthetic Biomanufacturing Industry Development White Paper" was officially released on August 1, highlighting the current state and trends of biomanufacturing [1]. - The report analyzes the global biomanufacturing industry, including key platform facilities and a comparative study of the US and China in this sector [7]. Group 2: Policy Landscape - The white paper outlines major domestic and international policies affecting biomanufacturing from 2024 to 2025, providing insights into regulatory frameworks [7]. Group 3: Industry Map and Applications - It presents a comprehensive map of the Chinese biomanufacturing industry and identifies key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [7]. Group 4: Key Enterprises - The report selects ten leading enterprises in the Chinese biomanufacturing sector and details the strategic directions of 15 listed companies in synthetic biology [7][8]. Group 5: Investment and Challenges - It discusses the investment landscape in synthetic biology from 2024 to mid-2025 and identifies challenges faced by the biomanufacturing industry in China, along with targeted policy recommendations [7].

Core Insights - The research team led by Professor Liu Liming from Jiangnan University has made significant progress in engineering Corynebacterium glutamicum for the production of 1,5-pentanediamine (PDA), a key monomer for bio-based polyamides, published in Bioresource Technology [2][3] - Traditional chemical synthesis of PDA is associated with high pollution and energy consumption, making microbial fermentation a more sustainable alternative, although high PDA concentrations pose cell toxicity challenges [2] Group 1 - The research identified a previously unreported toxicity cleavage issue during the fermentation process and implemented a dual tolerance engineering strategy [3] - A mutation in the lipoprotein gene cgl1283 (G345D) significantly improved extracellular PDA tolerance, increasing IC₅₀ from 33.5 g/L to 68.9 g/L [3] - Engineering modifications to the CgmA efflux transporter (M284A mutation) reduced intracellular PDA accumulation by 80.7%, alleviating cell toxicity [3] Group 2 - The optimized fermentation process achieved a PDA yield of 130 g/L, a glucose yield of 0.40 g/g, and a production rate of 3.94 g/L/h, all representing the highest reported values for PDA production via fermentation [3] - The study established a comprehensive framework integrating both intracellular and extracellular tolerance engineering, providing effective strategies for microbial production of high-toxicity, high-value chemicals [4] Group 3 - The first author of the paper is master's student Song Longfei, with Professor Liu Liming and Associate Researcher Gao Cong as corresponding authors [5] - The research team has conducted systematic studies in enzyme engineering and the construction of efficient cell factories for high-value compound synthesis, with several original research results published in prestigious journals [5]

Funding Sources - In the U.S., government funding is predominant, with the National Institutes of Health (NIH) leading basic research in biomanufacturing, while the Department of Energy (DOE) allocated $790 million for fusion research in FY 2025[5] - The European Union's Quantum Flagship program plans to invest approximately €1 billion over 10 years, with total investments in quantum technology reaching around €2 billion by 2024[10] - Japan's government initiated the "Moonshot R&D" program with an initial budget of ¥100 billion (approximately $900 million) to address structural societal challenges by 2050[13] Investment Mechanisms - The U.S. has established a stable budget mechanism through congressional authorization, with DARPA's budget increasing from approximately $2.27 billion in 1996 to over $4 billion in 2026, reflecting an annual growth rate of about 3%[16] - The EU's Multi-annual Financial Framework (MFF) locks in research funding for seven years, with the Horizon Europe program having a total budget of €95.5 billion for 2021-2027[17] - Japan's Strategic Innovation Promotion Program (SIP) operates on a rolling basis, allowing for adjustments based on project evaluations every five years[19] Risk Sharing - In the U.S., the federal government absorbs the risk of early-stage research failures in quantum technology, while companies like IBM and Google bear the risks during commercialization[20] - The EU employs a "first loss" mechanism where public funds cover a specific percentage of losses to improve the risk-return profile for private investors, with the European Investment Bank (EIB) providing guarantees to enhance project financing[21] - Japan's collaborative agreements between government and companies, such as NTT and Fujitsu, allow for shared risk in quantum technology development, integrating resources from universities and labs[23]

Conference Overview - The Fifth China Synthetic Biology and Biomanufacturing Conference will be held at the Hilton Garden Inn in Hangzhou on March 31 and April 1, 2026 [5][6] - The conference aims to gather industry experts and stakeholders to discuss advancements in synthetic biology and biomanufacturing [6][7] Registration and Participation - Free registration is available, with a limited number of spots, and participants are encouraged to share the event link on social media for additional benefits [4][38] - Attendees must wear their registration badges at all times during the conference [5] Transportation and Accommodation - Transportation options include taxi and metro services from Hangzhou East Station and Hangzhou Xiaoshan International Airport to the conference venue [5] - Recommended hotels include Hilton Garden Inn (550 RMB per night) and other nearby accommodations with varying prices [5] Weather Advisory - Participants are advised to prepare for significant temperature variations during the conference days [5] Conference Agenda - The conference will feature multiple sessions focusing on various aspects of synthetic biology, including biomanufacturing technologies, functional foods, and nutritional science [7][10] - Notable speakers include experts from universities and industry leaders discussing topics such as low-carbon biomanufacturing and the commercialization of synthetic biology products [9][10] Networking Opportunities - The event will provide networking opportunities through various forums and discussions, allowing participants to connect with industry peers and explore collaboration possibilities [6][7] Industry Insights - The conference will address the latest trends and innovations in the biomanufacturing sector, including the development of new materials and sustainable practices [10][23] - Discussions will also cover regulatory challenges and compliance in the synthetic biology field, particularly regarding new food and feed ingredients [16][30]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting new growth opportunities and aiding in industrial structure optimization and economic transformation [1]. Group 1: Current Status and Trends - The "2025 China Synthetic Biomanufacturing Industry Development White Paper" was officially released on August 1, highlighting the current state and trends of biomanufacturing [1]. - The report analyzes the global biomanufacturing industry, including key platform facilities and a comparative study of the U.S. and China in this sector [7]. Group 2: Policy Landscape - The white paper outlines major domestic and international policies affecting biomanufacturing from 2024 to 2025, providing insights into regulatory frameworks [7]. Group 3: Industry Map and Applications - It presents a comprehensive map of the Chinese biomanufacturing industry and identifies key application areas such as pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [7]. Group 4: Key Enterprises - The report selects ten leading enterprises in the Chinese biomanufacturing sector and details the strategic directions of 15 listed companies in synthetic biology [7][8]. Group 5: Investment and Challenges - It discusses the investment landscape in synthetic biology from 2024 to mid-2025 and addresses the challenges faced by the biomanufacturing industry in China, along with proposed countermeasures [7].

Conference Overview - The Fifth China Synthetic Biology and Biomanufacturing Conference will be held on March 31 to April 1, 2026, at the Hilton Garden Inn Hangzhou [7] - The conference aims to gather 1,000 participants and is organized by Synbio Deep Wave in collaboration with Jiangnan University [7] Registration and Participation - Free registration is available, but limited to a certain number of participants on a first-come, first-served basis [33] - Attendees can participate in a "Share to Get Manual" activity to receive a free 500-page "China Biomanufacturing Industry Policy Compilation" by sharing the event link [4] Transportation and Accommodation - Transportation options include taxi and metro services from Hangzhou East Station and Hangzhou Xiaoshan International Airport to the conference venue [5] - Recommended hotels include Hilton Garden Inn Hangzhou with a room rate of 550 CNY per night and other budget options starting from 238 CNY [5] Agenda Highlights - The conference features multiple sessions focusing on various aspects of biomanufacturing, including green manufacturing, functional food, and the integration of AI in biomanufacturing [9][10][24] - Notable speakers include experts from universities and industry leaders discussing topics such as low-carbon biomanufacturing technologies and the commercialization of synthetic biology [9][10] Networking Opportunities - The event will provide platforms for networking, including roundtable discussions and project matchmaking sessions for biomanufacturing innovation [11][22] - Participants will have opportunities to engage with industry leaders and explore collaborative projects in synthetic biology [29]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative sector, which is seen as a new growth point that can drive industrial structure optimization and economic model transformation. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper provides an overview of the development status and trends of biomanufacturing, analyzing the industry chain and key application directions [1]. - It compares the competitive landscape of biomanufacturing between China and the United States, identifying key differences and opportunities [7]. - Future development trends in biomanufacturing are discussed, indicating potential areas for growth and innovation [7]. Group 2: Policy Landscape - The report outlines major domestic and international policies affecting the biomanufacturing sector for 2024-2025, providing insights into regulatory environments [7]. - It details foreign policies that influence the global biomanufacturing industry, as well as domestic policies that shape the Chinese market [7]. Group 3: Industry Mapping and Key Players - The white paper identifies the "10 Leading Enterprises" in China's biomanufacturing industry, showcasing significant players and their contributions [7]. - It lists 15 publicly listed companies involved in synthetic biology, summarizing their strategic directions and investments in the field [7]. - The report highlights 20 popular products in the biomanufacturing space, linking them to corresponding companies [7]. Group 4: Challenges and Recommendations - The document discusses the challenges faced by China's biomanufacturing industry, including technological, regulatory, and market-related issues [7]. - It offers targeted policy recommendations to address these challenges, aiming to support the sustainable development of the biomanufacturing sector [7].

主办单位 ：浙江省全省生物基高分子材料重点实验室、宁波德泰中研信息科技有限公司（DT新材料） 协办单位 ：生物基纤维材料全国重点实验室、先进造纸与纸基材料全国重点实验室、中国生物工程学会生物基材料专委会 支持单位 ：中国出口商品包装研究所、中国合成橡胶工业协会热塑性弹性体分会（TPE分会）、中国化工学会橡塑绿色制造专业委员会、工程和生态塑料国家工 程研究中心、生物质产业碳中和技术创新联盟、生物基尼龙纺织产业联盟 专场冠名 ：苏尔寿化工、利夫生物... ... 时间地点 ：5月20-22日；中国 · 上海富悦大酒店 【SynBioCon】 获悉，3月12日，十四届全国人大四次会议表决通过了《 中华人民共和国国民经济和社会发展第十五个五年规划纲要 》，共分为18 篇，其中多处提及新能源、新能源汽车、机器人、 生物制造 、高端装备、航空航天、量子科技、氢能和核聚变能、脑机接口、具身智能等新兴和未来 产业。 来源：中国人民政府网 值得一提的是，《纲要》明确提及多个细分新材料品类，包括： 生物基材料 ， 生物制造、生物能源 ，这是生物基材料首次写进国家五年规划纲要 ： 第二篇 建设现代化产业体系 巩固壮大实体经济根基 ...